Tyra Biosciences, Inc.TYRANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P67
Within normal range
vs 2Y Ago
-125.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-36.36%
2024-39.16%
20230.29%
2022-111.77%
2021-205.87%
2020-196.52%
20190.00%